Business Description
PolyPid Ltd
ISIN : IL0011326795
Total Employee Number:
75Description
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.18 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | -0.05 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 67.6 | |||||
3-Year EPS without NRI Growth Rate | 67.8 | |||||
3-Year FCF Growth Rate | 68.6 | |||||
3-Year Book Growth Rate | -59.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 37.93 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.98 | |||||
9-Day RSI | 66.65 | |||||
14-Day RSI | 62.37 | |||||
3-1 Month Momentum % | 4.76 | |||||
6-1 Month Momentum % | 15.51 | |||||
12-1 Month Momentum % | 39.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.14 | |||||
Cash Ratio | 0.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -201.8 | |||||
Shareholder Yield % | 6.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -258.28 | |||||
ROA % | -129.92 | |||||
ROIC % | -306.13 | |||||
3-Year ROIIC % | -78.54 | |||||
ROC (Joel Greenblatt) % | -478.16 | |||||
ROCE % | -201.85 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 19.13 | |||||
Price-to-Tangible-Book | 19.13 | |||||
EV-to-EBIT | -3.13 | |||||
EV-to-EBITDA | -3.13 | |||||
EV-to-Forward-Revenue | 12.91 | |||||
EV-to-FCF | -3.56 | |||||
Earnings Yield (Greenblatt) % | -31.95 | |||||
FCF Yield % | -26.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PYPD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PolyPid Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.48 | ||
| Beta | 1.2783 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 32.16 | ||
| 14-Day RSI | 62.37 | ||
| 14-Day ATR ($) | 0.262461 | ||
| 20-Day SMA ($) | 5.04575 | ||
| 12-1 Month Momentum % | 39.88 | ||
| 52-Week Range ($) | 3.06 - 5.73 | ||
| Shares Outstanding (Mil) | 20.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PolyPid Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PolyPid Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-25 | In 169 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-11 08:30 | In 156 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-11 | In 155 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-12 08:30 | In 65 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 64 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 08:30 | 4.73 (-1.05%) | ||
| Second quarter earnings results for 2026 | 2026-08-12 | 4.73 (-1.05%) | ||
| General meeting for 2026 | 2026-07-15 14:00 | 5.35 (+5.11%) | ||
| Craig-Hallum 23rd Annual Institutional Investor Conference | 2026-05-28 | 4.77 (-2.65%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 08:30 | 4.56 (+7.80%) |
Show
Entries
PolyPid Ltd Frequently Asked Questions
What is PolyPid Ltd(PYPD)'s stock price today?
The current price of PYPD is $5.17. The 52 week high of PYPD is $5.73 and 52 week low is $3.06.
When is next earnings date of PolyPid Ltd(PYPD)?
The next earnings date of PolyPid Ltd(PYPD) is 2026-11-12 Est..
Does PolyPid Ltd(PYPD) pay dividends? If so, how much?
PolyPid Ltd(PYPD) does not pay dividend.
Press Release
Articles on PolyPid Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers